Literature DB >> 25950168

Effect of dexamethasone on mandibular bone biomechanics in rats during the growth phase as assessed by bending test and peripheral quantitative computerized tomography.

Clarisa Bozzini1, Graciela Champin1, Rosa M Alippi1, Carlos E Bozzini1.   

Abstract

Long-term glucocorticoid administration to growing rats induces osteopenia and alterations in the biomechanical behavior of the bone. This study was performed to estimate the effects of dexamethasone (DTX), a synthetic steroid with predominant glucocorticoid activity, on the biomechanical properties of the mandible of rats during the growth phase, as assessed by bending test and peripheral quantitative computed tomographic (pQCT) analysis. The data obtained by the two methods will provide more precise information when analyzed together than separately. Female rats aged 23 d (n=7) received 500μg.kg-1 per day of DXT for 4 weeks. At the end of the treatment period, their body weight and body length were 51.3% and 20.6% lower, respectively, than controls. Hemimandible weight and area (an index of mandibular size) were 27.3% and 9.7% lower, respectively. The right hemimandible of each animal was subjected to a mechanical 3-point bending test. Significant weakening of the bone, as shown by a correlative impairment of strength and stiffness, was observed in experimental rats. Bone density and cross-sectional area were measured by pQCT. Cross-sectional, cortical and trabecular areas were reduced by 20% to 30% in the DTX group, as were other cortical parameters, including the bone density, mineral content and cross-sectional moment of inertia. The "bone strength index" (BSI, the product of the pQCT-assessed xCSMI and vCtBMD) was 56% lower in treated rats, which compares well with the 54% and 52% reduction observed in mandibular strength and stiffness determined through the bending test. Data suggest that the corticosteroid exerts a combined, negative action on bone geometry (mass and architecture) and volumetric bone mineral density of cortical bone, which would express independent effects on both cellular (material quality) and tissue (cross-sectional design) levels of biological organization of the skeleton in the species.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25950168     DOI: 10.1590/S1852-48342015000100012

Source DB:  PubMed          Journal:  Acta Odontol Latinoam        ISSN: 0326-4815


  2 in total

1.  Dexamethasone Down-regulates Osteocalcin in Bone Cells through Leptin Pathway.

Authors:  Shu-Mei Chen; Yi-Jen Peng; Chih-Chien Wang; Sui-Lung Su; Donald M Salter; Herng-Sheng Lee
Journal:  Int J Med Sci       Date:  2018-03-08       Impact factor: 3.738

2.  Glucocorticoids cause mandibular bone fragility and suppress osteocyte perilacunar-canalicular remodeling.

Authors:  A Sean Alemi; Courtney M Mazur; Tristan W Fowler; Jonathon J Woo; P Daniel Knott; Tamara Alliston
Journal:  Bone Rep       Date:  2018-10-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.